Dialybrid @ VAS 2023, Porto

Dialybrid’s Project Coordinator, Stefania A. Riboldi, was present with an oral presentation at the 13th Congress of The Vascular Access Society, held in Porto (Portugal), April 27th-29th, 2023. The title of the speech was “Evaluation of safety and performances of…

Read More
Dialybrid Foundation

LIFTT, the investment operating company founded by Fondazione Compagnia Di San Paolo and Politecnico di Torino, and Bioengineering Laboratories S.r.l. (“BEL”), a medical device company controlled by the Delta Med group and its founder Francesco Greco, join in a strategic-financialpartnership…

Read More
Silkothane® Graft @ Vas 2019, Rotterdam

SAG (Silkothane® Arteriovenous Graft) is present with a poster at the 11th Congress of The Vascular Access Society. Rotterdam (The Netherlands), April 11th-13th, 2019.  van Uden S, Catto V, Vanerio N, Bonandrini B, Tironi M, Figliuzzi M, Remuzzi A, Kock…

Read More
Dialybrid @ Termis 2018 Business Plan Competition

The Dialybrid project is awarded the second prize at the Business Plan Competition of the 5th World Congress of TERMIS – Tissue Engineering and Regenerative Medicine International Society in September 2018 (Kyoto, Japan). Dialybrid’s business plan and presentation pitch focuses…

Read More
Silkothane® Graft @ Termis 2018, Kyoto

SAG (Silkothane® Arteriovenous Graft) is present with a poster at the 5th World Congress of the Tissue Engineering and Regenerative Medicine Society (TERMIS). Kyoto (Japan), September 4th-7th, 2018. van Uden S, Catto V, van der Donk L, Vanerio N, Kock…

Read More
Silkothane® Graft @ Insubria Diva 2017, Como

SAG (Silkothane® Arteriovenous Graft) is present with an oral presentation at INSUBRIA DIVA V – Workshop on Vascular Accesses. Como (Italy), October 3rd, 2017. van Uden S, Greco FG, Galli F, Tozzi M, Carbonari L, Riboldi SA. A hybrid and…

Read More
Silkothane® Graft @ Termis 2017, Davos

SAG (Silkothane® Arteriovenous Graft) is present with a poster at the European Chapter Meeting of the Tissue Engineering and Regenerative Medicine Society (TERMIS-EU). Davos (Switzerland), June 26th-30th, 2017. van Uden S, Catto V, Greco FG, Redaelli A, Riboldi SA. Hybrid…

Read More